412 BMS-754807, an oral dual IGF-1R/insulin receptor (IR) inhibitor: initial results from a Phase 1 dose- and schedule-finding study in combination with carboplatin/paclitaxel in subjects with solid tumors Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Chu, QS
  • Kim, SW
  • Ellis, Peter
  • Mileshkin, L
  • de Boer, RH
  • Park, JS
  • Pellas, T
  • Huang, F
  • Finckenstein, F Graf
  • Dhar, A

publication date

  • November 2010